Journal
KIDNEY INTERNATIONAL
Volume 81, Issue 2, Pages 127-129Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ki.2011.301
Keywords
-
Categories
Funding
- NIDDK NIH HHS [R21 DK090548, R01 DK090058-01, R01 DK090058] Funding Source: Medline
Ask authors/readers for more resources
Cystinosis as a clinical entity is a progressive dysfunction of multiple organs caused by the accumulation of cystine in the tissues, leading, for example, to end-stage renal failure, diabetes, hypothyroidism, myopathy, and central nervous system deterioration. Brodin-Sartorius and colleagues present a long-term study on the impact of cysteamine therapy on these complications. The data show that cysteamine improves the outcome and complications of cystinosis but does not prevent them. Kidney International (2012) 81, 127-129. doi:10.1038/ki.2011.301
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available